Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Public ClinicalTrials.gov record NCT01174030. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 4-week, Randomized, Double-blind, Parallel-group, Vehicle-controlled, Multicenter Study Investigating the Efficacy and Safety of CD07805/47 Gel 0.5% Applied Topically Once Daily (QD), and CD07805/47 Gel 0.18% Applied Topically Once Daily (QD) or Twice Daily (BID), in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this vehicle controlled study is to evaluate the efficacy and safety of CD07805/47 gel 0.5% applied topically once daily (QD) for 4 weeks, and CD07805/47 gel 0.18% applied topically once daily (QD) or twice daily (BID) for 4 weeks, in subjects with moderate to severe facial erythema associated with rosacea.
Study identification
- NCT ID
- NCT01174030
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 269 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2010 (Type not available)
- Primary completion
- Dec 2010 (Actual)
- Completion
- Jan 2011 (Actual)
- Last update posted
- Feb 26, 2021
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| University of California at San Francisco | San Francisco | California | 94143-0660 | — |
| Meda Phase, Inc | Newnan | Georgia | 30263 | — |
| Dermatology Specialists PC | Louisville | Kentucky | 40202 | — |
| Minnesota Clinical Study Center | Fridley | Minnesota | 55432 | — |
| Central Dermatology, PC | St Louis | Missouri | 63117 | — |
| Skin Specialty Group | New York | New York | 10021 | — |
| Dermatology Laser & Vein Specialists | Charlotte | North Carolina | 28207 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Oregon Dermatology & Research Center | Portland | Oregon | 97210 | — |
| Oregon Medical Research | Portland | Oregon | 97223 | — |
| Philadelphia Institute of Dermatology | Fort Washington | Pennsylvania | 19034 | — |
| DermDox | Hazleton | Pennsylvania | 18201 | — |
| Palmetto Clinical Trial Services, LLC | Greenville | South Carolina | 29007 | — |
| The Skin Wellness Center | Knoxville | Tennessee | 37902 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| The Education & Research Foundation | Lynchburg | Virginia | 24501 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
| Madison Skin & Research | Madison | Wisconsin | 53719 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01174030, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01174030 live on ClinicalTrials.gov.